We have located links that may give you full text access.
The 'PD Warrior' exercise program improves motor outcomes and quality of life in patients with early Parkinson's disease: results of a pilot study.
Internal Medicine Journal 2023 December 15
BACKGROUND: 'PD Warrior' (PDW) is a popular exercise program for Parkinson's disease; however, there are no published studies on the outcomes of the program.
AIMS: To investigate short-term functional and quality of life (QoL) outcomes after the PDW 10-week program in a pilot study of individuals with early Parkinson's Disease (PD).
METHODS: Twenty individuals with PD (Hoehn & Yahr 1-3) attending a hospital outpatient clinic were recruited into the PDW 10-week program, comprising a weekly 1-h supervised class complemented by an individualised daily home exercise program. Participants had the following assessments at baseline and after completion of the program: Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III, timed up-and-go (TUG), 10-m walk test (10mWT), 6-min walking test (6MWT), balance tests, fine motor skills, 7-day Parkinson's KinetiGraph (PKG) and PDQ-39 QoL scale.
RESULTS: Seventeen individuals completed the program. Significant improvements were observed in MDS-UPDRS motor score (P = 0.019, d = 0.68, MCID 7); 6MWT distance (P < 0.001, d = 1.16); walking time during motor or cognitive dual tasking (P = 0.006, d = 0.77; P = 0.005, d = 0.79, respectively); and the PDQ-39 emotional well-being subdomain (P = 0.009; MCID 4.2); as well as improvements trending to significance in bradykinesia (P = 0.025, d = 0.73), 10mWT walking time (P = 0.023, d = 0.61) and borderline improvement in balance (P = 0.056, d = 0.50).
CONCLUSIONS: The outcomes of this study support the efficacy of the PDW program in individuals with early PD and provide justification for future trials and investigation of its effects.
AIMS: To investigate short-term functional and quality of life (QoL) outcomes after the PDW 10-week program in a pilot study of individuals with early Parkinson's Disease (PD).
METHODS: Twenty individuals with PD (Hoehn & Yahr 1-3) attending a hospital outpatient clinic were recruited into the PDW 10-week program, comprising a weekly 1-h supervised class complemented by an individualised daily home exercise program. Participants had the following assessments at baseline and after completion of the program: Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III, timed up-and-go (TUG), 10-m walk test (10mWT), 6-min walking test (6MWT), balance tests, fine motor skills, 7-day Parkinson's KinetiGraph (PKG) and PDQ-39 QoL scale.
RESULTS: Seventeen individuals completed the program. Significant improvements were observed in MDS-UPDRS motor score (P = 0.019, d = 0.68, MCID 7); 6MWT distance (P < 0.001, d = 1.16); walking time during motor or cognitive dual tasking (P = 0.006, d = 0.77; P = 0.005, d = 0.79, respectively); and the PDQ-39 emotional well-being subdomain (P = 0.009; MCID 4.2); as well as improvements trending to significance in bradykinesia (P = 0.025, d = 0.73), 10mWT walking time (P = 0.023, d = 0.61) and borderline improvement in balance (P = 0.056, d = 0.50).
CONCLUSIONS: The outcomes of this study support the efficacy of the PDW program in individuals with early PD and provide justification for future trials and investigation of its effects.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app